[Immunosuppression may mask severe infection. Septic arthritis in tocilizumab treatment yielded only modest acute-phase reaction]

Lakartidningen. 2012 Sep;109(38):1678-9.
[Article in Swedish]
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Antirheumatic Agents / adverse effects*
  • Antirheumatic Agents / therapeutic use
  • Arthritis, Infectious / diagnosis*
  • Arthritis, Rheumatoid / complications
  • Arthritis, Rheumatoid / drug therapy*
  • C-Reactive Protein / analysis
  • Humans
  • Immunosuppressive Agents / adverse effects*
  • Immunosuppressive Agents / therapeutic use
  • Male
  • Middle Aged
  • Receptors, Interleukin-6 / antagonists & inhibitors
  • Risk Factors
  • Staphylococcus aureus / isolation & purification

Substances

  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents
  • Immunosuppressive Agents
  • Receptors, Interleukin-6
  • C-Reactive Protein
  • tocilizumab